ClinicalTrials.gg
CompletedNCT02975414Robust_2Updated Dec 24, 2018

Robotic Utility for Surgical Treatment of Umbilical Hernias

An observational study in Hernia, Umbilical, sponsored by Filip Muysoms. Completed at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2018-12-24.

Sponsored by Filip Muysoms · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45
Sex
All
01

Study summary

The purpose of this study is the measurement of the evolution of the operation time during the start-up phase of robotic assisted surgery for the treatment of incisional hernia's of 40 patients treated in Maria Middelares in laparoscopic rTARUP technique.

Read the detailed description

Minimally invasive hernia repair by laparoscopy is the standard treatment in adult patients with an umbilical hernia larger than 2 cm in Maria Middelares, Ghent.

As previously described in a chapter in a surgical guide and in a review article on the surgical fixation technique for laparoscopic umbilical hernia repair, the used technique has been proven feasible end safe.

Robot-assisted laparoscopic surgery has become standard in urology for resection of the prostate carcinoma. In general abdominal surgery, a large group of surgeons are currently working on the introduction of robotic-assisted surgery for resection of colon and rectal cancer in their daily practice. The third generation robot (DaVinci Xi), has extended the applicability of this technology within the field of general surgery.

For the surgical treatment of hernia's and other abdominal wall defects (umbilical or/and incisional hernia's), currently only surgeons in the US have experiences in structured treatment programs.

From September 1, 2016 Maria Middelares hospital will introduce robot-assisted surgery, including the laparoscopic TARUP umbilical hernia repair.

Main obstacles to the introduction of robot technology in abdominal wall surgery are prolonged preparation time in the operating room required for installation of the robot, and higher material costs related to the robot-assisted surgery. However, there are few precise data available on the exact size of extra time or increased costs related to the introduction of robotic assisted surgery in a program for abdominal surgery.

The purpose of this study is the measurement of the evolution of the operation time during the start-up phase of robotic-assisted surgery for the treatment of umbilical hernias by 40 patients in Maria Middelares hospital.

02

Conditions studied

  • Hernia, Umbilical

Browse trials for

03

In context

Hernia, Umbilical

67 studies on the registry are indexed under Hernia, Umbilical; 13 are open to participants now.

This study's enrollment of 45 is below the median of 118 across 25 observational studies indexed under Hernia, Umbilical.

Browse Hernia, Umbilical studies →

Lead sponsor

Filip Muysoms is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All eligible patients who are scheduled for laparoscopic repair of an umbillical hernia. A total of 40 patients will be enrolled in this observational study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 40 patients selected and operated by the PI.

Exclusion criteria

Exclusion Criteria:

  • patients under the age of 18
  • pregnancy
  • no
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45 participants (actual)
Patient registry
No

Interventions

  • ProcedurerTARUP technique

    obot-assisted rTARUP technique

06

What researchers measure

Primary outcomes

  1. duration of operation

    Recording of the operation time needed for robot-assisted TARUP umbilical hernia repair

    Time frame: from the start of the operation until the end of the operation, approximately 4 hours

Secondary outcomes

  1. intra-operative complications

    Intra-operative complications registered until 4 weeks after the hernia repair

    Time frame: until 4 weeks post-operative

  2. post-operative complications

    Post-operative complications detected until 1 year after hernia repair by clinical follow up.

    Time frame: until 1 year post-operative

  3. Questionnaire about the Quality of Life

    Quality of Life measured with the EuraHS QoL score preoperative and until 1 year after hernia repair by clinical follow up.

    Time frame: until 1 year post-operative

07

Study locations

1 site
  • AZ Maria Middelares
    Ghent, 9000, Belgium
08

References and documents

Publications

  • Muysoms F, Van Cleven S, Pletinckx P, Ballecer C, Ramaswamy A. Robotic transabdominal retromuscular umbilical prosthetic hernia repair (TARUP): observational study on the operative time during the learning curve. Hernia. 2018 Dec;22(6):1101-1111. doi: 10.1007/s10029-018-1825-x. Epub 2018 Sep 22. PubMed 30244344 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2016, a primary completion of Dec 2018 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2016
First posted
Nov 29, 2016
Start
Sep 2016
Primary completionActual
Dec 17, 2018
CompletionActual
Dec 17, 2018
Last update
Dec 24, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02975414
Lead sponsor
Filip Muysoms
Responsible party
Filip Muysoms (surgeon, Algemeen Ziekenhuis Maria Middelares) — Sponsor-investigator
First posted
Nov 29, 2016
Start date
Sep 2016
Primary completion
Dec 17, 2018
Completion
Dec 17, 2018
Last update
Dec 24, 2018

Study contacts

Filip Muysoms, MD, PhD
principal investigator · Maria Middelares hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion